Arich Enterprise Co., Ltd. (TPEX: 4173)
Taiwan
· Delayed Price · Currency is TWD
22.00
+0.05 (0.23%)
Dec 31, 2024, 1:30 PM CST
Arich Enterprise Revenue
Arich Enterprise had revenue of 317.29M TWD in the quarter ending June 30, 2024, with 8.26% growth. This brings the company's revenue in the last twelve months to 1.21B, up 12.34% year-over-year. In the year 2023, Arich Enterprise had annual revenue of 1.14B with 11.99% growth.
Revenue (ttm)
1.21B
Revenue Growth
+12.34%
P/S Ratio
1.37
Revenue / Employee
6.12M
Employees
198
Market Cap
1.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.14B | 122.06M | 11.99% |
Dec 31, 2022 | 1.02B | 72.36M | 7.65% |
Dec 31, 2021 | 945.66M | -305.73M | -24.43% |
Dec 31, 2020 | 1.25B | 139.25M | 12.52% |
Dec 31, 2019 | 1.11B | -189.61M | -14.57% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Lotus Pharmaceutical | 17.59B |
Oneness Biotech | 112.20M |
Lumosa Therapeutics | 37.82M |
Polaris Group | 75.65M |
Center Laboratories | 1.57B |
Pegavision | 7.06B |
TaiMed Biologics | 622.61M |